Related Experiment Videos
Current bladder cancer tests: unnecessary or beneficial?
Michael A Simon1, Vinata B Lokeshwar, Mark S Soloway
1Scott Department of Urology, Baylor College of Medicine, 6560 Fannin Street, Suite 2100, Houston, TX 77030-2769, USA. msimonmd@hotmail.com
Critical Reviews in Oncology/Hematology
|August 6, 2003
Summary
Diagnosing bladder cancer relies on cystoscopy and cytology, but new non-invasive urine tests offer improved sensitivity and specificity for detecting bladder tumors. These advancements aim for ideal diagnostic criteria, including ease of use and reproducibility.
Area of Science:
- Urology
- Oncology
- Biomarker Discovery
Background:
- Current bladder cancer diagnosis involves cystoscopy and cytology, which are invasive and have limitations.
- Bladder cancer recurrence rates are high, requiring frequent monitoring.
- Urine cytology, while specific, lacks sensitivity for low-grade tumors and is resource-intensive.
Purpose of the Study:
- To review the development and performance of non-invasive urine tests for bladder cancer diagnosis.
- To evaluate how newly developed tests align with the criteria for an ideal bladder cancer diagnostic tool.
Main Methods:
- Review of recently developed non-invasive bladder cancer tests utilizing urinary markers.
- Analysis of FDA-approved and investigational urine-based diagnostic assays.
- Assessment of diagnostic performance against ideal criteria: non-invasiveness, sensitivity, specificity, cost, ease of use, and reproducibility.
Main Results:
- Several non-invasive urine tests have been developed, with some approved by the FDA.
- These tests utilize various urinary biomarkers for bladder cancer detection.
- No single test currently meets all criteria for an ideal diagnostic tool, though many show promise.
Conclusions:
- Non-invasive urine tests represent a significant advancement in bladder cancer diagnostics and monitoring.
- Further development is needed to achieve a test that is highly sensitive, specific, cost-effective, and easy to perform.
- The ongoing research aims to improve early detection and reduce the burden of bladder cancer management.